November 29, 2010 09:09 ET

Asia-Pacific Biotech Market Projected to Grow 16% Annually Through 2012

ROCKVILLE, MD--(Marketwire - November 29, 2010) - has announced the addition of RNCOS's new report "Asia Pacific Biotechnology Market (2008-2012)" to their collection of Biotechnology market reports. For more information, visit

The biotechnology market in the Asia-Pacific region seems very lucrative from an investment perspective, as it has enjoyed double-digit growth during the past few years. The industry is attracting more and more private investments in wake of immense growth opportunities and vast untapped biotech markets. Identifying the future growth potential of the industry, the governments of different countries in the Asia-Pacific region are taking up various initiatives to promote research in this region. Overall, the Asia-Pacific biotech market is expected to spur future growth in the global biotechnology market.

According to the new research report, "Asia Pacific Biotechnology Market (2008-2012)," the Asia-Pacific biotech market is projected to grow at a CAGR of around 16% during 2010 - 2012. Our research has found that at the regional forefront, Japan and China are dominating this industry, while higher growth rates have been witnessed in emerging markets like Malaysia, India, and Singapore. These countries are anticipated to dominate the market in the future with a combined share of around 70% of overall market.

In depth analysis of the market has shown that various factors such as the emerging biosimilar market and various others discussed in the report will drive the future growth of the industry. On account of wide application areas ranging from infectious diseases to autoimmune diseases, companies have started research and development programs on developing biosimilars to acquire the market space as soon as possible.

The report also provides extensive information and data of the biotech market in the Asia-Pacific region. The report also discusses the emerging trends like contract research and manufacturing, bioinformatics, generics market etc. It provides valuable information to pharmaceutical & biotechnology companies and investors, planning to enter these markets and will help them to devise strategies in accordance to the individual markets. The report also contains detailed analysis and statistics of the market size, growth, share, segmentation, geographic distribution, trends in technology development, and profiling of key players of each country.

For more information, visit

Contact Information